CGEM — CULLINAN ONCOLOGY INC

Ownership history in BVF INC/IL  ·  20 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in CULLINAN ONCOLOGY INC (CGEM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.65% (2022 Q2)
Avg. % of fund
2.01%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 5,750,683 — 0% 2.00% $59.5M $10.35
2025 Q3 UNCHANGED 5,750,683 — 0% 1.38% $34.1M $5.93
2025 Q2 UNCHANGED 5,750,683 — 0% 1.55% $43.3M $7.53
2025 Q1 UNCHANGED 5,750,683 — 0% 1.77% $43.5M $7.57
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CGEM price (monthly, adj. close)

Other funds also holding CGEM

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 18.78% MPM BioImpact LLC 3Y 9.06% GREAT POINT PARTNERS LLC 3Y 7Y 2.13% Kynam Capital Management, LP 3Y 2.06% Blue Owl Capital Holdings LP 3Y 1.82% Affinity Asset Advisors, LLC 3Y 1.14% Elmind Capital, LP 0.95% TWIN FOCUS CAPITAL PARTNERS, LLC 3Y 7Y 0.71% VR Adviser, LLC 3Y 0.71% Siren, L.L.C. 0.37%
← Back to BVF INC/IL Holdings